# |
PMID |
Sentence |
1 |
7595601
|
The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies.
|
2 |
7595601
|
Because of its multi-faceted potential as a neurotrophic factor, insulin-like growth factor I (IGF-I) has been given to hundreds of ALS patients world-wide.
|
3 |
7595601
|
We found that about 25% of ALS patients in a controlled trial of human growth hormone (hGH) had lower or higher than normal IGF-I serum levels.
|
4 |
7595601
|
Many ALS patients do have some of the characteristics of type II diabetes mellitus, where IGF-I therapy is also under way.
|
5 |
7595601
|
In addition, in type I diabetes significant increase in a circulating molecule that binds IGF-I, IGF-I binding protein 1 (IGFBP-1), occurs along with reduced IGF-I, when neuropathic complications are prominent.
|
6 |
7595601
|
We have studied the response of IGFBPs in ALS patients to subcutaneous rhIGF-I and found transient induction of IGFBP-1.
|
7 |
7595601
|
However, the gene for another IGFBP, BP-2, co-localizes with the gene for juvenile ALS (ALSJ) on chromosome 2.
|